INSIGHTS+ Insights+: The US FDA New Drug Approvals in July 2024ByDipanshu DixitAugust 13, 20240Comments
News Galderma Reports the US FDA’s Approval of Nemluvio (Nemolizumab) for Treating Prurigo Nodularis (PN) ByDipanshu DixitAugust 13, 20240Comments
SPOTLIGHT CXO Talks: Nick Kadysh the Founding CEO & President at PharmAla Biotech, in an Illuminating Dialogue Exchange with PharmaShotsByHimanshu SehgalAugust 12, 20240Comments
THOUGHTSPOT How Can ABA Practice Management Software Simplify Your Administrative Work?ByEvans JamesAugust 12, 20240Comments
THOUGHTSPOT Holistic Mental Health Care: The Dual Role of Medication and TherapyByCarla AdamsAugust 12, 20240Comments
News Sandoz Reports the US FDA’s Approval of Enzeevu (Biosimilar, Eylea) to Treat Neovascular Age-Related Macular Degeneration ByDipanshu DixitAugust 12, 20240Comments
THOUGHTSPOT Digital Health Innovations Reshaping the Pharmaceutical IndustryByJohn CunninghamAugust 9, 20240Comments
News Ascendis Pharma’s Yorvipath Receives the US FDA’s Approval to Treat Hypoparathyroidism ByDipanshu DixitAugust 9, 20240Comments
THOUGHTSPOT Tearing the Silence: Addressing Common Postpartum ConcernsByJehan AraAugust 8, 20240Comments
